CB25826-1 - 0x000000000000392F

Study Number: CB25826
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 4,400

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat leukemia.
  • Route of Administration: Oral
  • Blood Draws: 42

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 21 Night Stay & 1 Return

Screening Dates:

Event Day Event Date Site
Thursday Oct 18 2018 Belfast
Thursday Oct 25 2018 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Thursday Oct 18 2018 Belfast
Thursday Oct 25 2018 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday Nov 3 2018 11:00AM Nov 24 2018 9:00AM 1 Belfast
Return Saturday Dec 22 2018 7:30AM Saturday Dec 22 2018 9:00AM 3 Belfast